- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No specific data available about the pharmacokinetics in children.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Available formulations
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Dosages
| Incompatible transfusion of red blood cells |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
In the event of a large volume needing to be administered (> 2 ml for children or > 5 ml for
adults), it is recommended that this should be given as two injections at different
sites.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Immunoglobulins, normal human | ||
|---|---|---|
| J06BA02 | ||
| J06BA01 | ||
| Specific immunoglobulins | ||
|---|---|---|
| J06BB04 | ||
| J06BB02 | ||
| J06BB03 | ||
| Antibacterial monoclonal antibodies | ||
|---|---|---|
| J06BC03 | ||
| IMMUNOGLOBULINS, NORMAL HUMAN | ||
|---|---|---|
| J06BA02 | ||
| J06BA01 | ||
| Antiviral monoclonal antibodies | ||
|---|---|---|
| J06BD07 | ||
| J06BD08 | ||
| J06BD01 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
References
- Sanquin, SmPC RheDQuin (RVG 16928) 23-04-2010, www.cbg-meb.nl, Geraadpleegd 14-04-2014
- CSL Behring GmbH, SmPC Rhophylac (RVG 27449) 11-11-2013, www.cbg-meb.nl, Geraadpleegd 14-04-2014
- EuroCept bv, SmPC Rhesonativ (RVG 33233) 28 mrt 2014, www.cbg-meb.nl
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Changes
Changes
